SCHEMBL23091188

SCHEMBL23091188

COc1ccc(-c2ccc(C(=O)Nc3cccnc3)o2)cc1OC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.72
▸ NPC1 O15118 6/20 0.72
▸ TP53 P04637 2/20 0.72
▸ MAPK1 P28482 3/20 0.67
▸ POLB P06746 1/20 0.67
▸ LMNA P02545 4/20 0.64
▸ ALDH1A1 P00352 6/20 0.63
▸ KDM4E B2RXH2 6/20 0.63
▸ MAPT P10636 6/20 0.63
▸ SMN1; SMN2 Q16637 3/20 0.63
▸ HSD17B10 Q99714 2/20 0.63
▸ USP2 O75604 1/20 0.63
▸ CYP1A2 P05177 2/20 0.56
▸ CYP3A4 P08684 2/20 0.56
▸ HPGD P15428 2/20 0.56
▸ CYP2C19 P33261 2/20 0.56
▸ CYP2D6 P10635 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ GAA P10253 1/20 0.56
▸ MEN1 O00255 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23091169 0.91 NPC1 (0.64) RAB9ANPC1TP53MAPK1POLB
SCHEMBL30501668 0.91 NPC1 (0.64) RAB9ANPC1TP53MAPK1POLB
SCHEMBL23091224 0.82 NPC1 (0.77) RAB9ANPC1TP53MAPK1POLB
SCHEMBL30501715 0.82 NPC1 (0.77) RAB9ANPC1TP53MAPK1POLB
SCHEMBL23091241 0.81 RAB9A (0.69) RAB9ANPC1TP53MAPK1POLB
SCHEMBL23091167 0.81 NPC1 (0.67) RAB9ANPC1TP53MAPK1POLB
SCHEMBL12978269 0.78 LMNA (1.00) RAB9ANPC1TP53MAPK1POLB
SCHEMBL30501738 0.77 PTPN1 (0.61) RAB9ANPC1MAPK1POLBLMNA
SCHEMBL23091179 0.77 PTPN1 (0.61) RAB9ANPC1MAPK1POLBLMNA
SCHEMBL23091200 0.76 MAPK1 (0.67) RAB9ANPC1TP53MAPK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3805210-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Autophagysciences, Inc (KR) 2021-04-14 — — EP claimed
US-20210078987-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Autophagysciences Inc. (KR) 2021-03-18 — — US claimed
EP-3805210-B1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AUTOPHAGYSCIENCES INC (KR) 2023-11-29 — — EP disclosed
EP-3805210-B1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AUTOPHAGYSCIENCES INC (KR) 2023-11-29 — — EP disclosed
CN-112004807-B Compounds and pharmaceutical compositions comprising the same 自体吞噬科学有限公司 2023-07-18 — — CN disclosed
US-11407744-B2 Compound and pharmaceutical composition comprising same Autophagysciences Inc. (KR) 2022-08-09 — — US disclosed
EP-3805210-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Autophagysciences, Inc (KR) 2021-04-14 — — EP disclosed
US-20210078987-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Autophagysciences Inc. (KR) 2021-03-18 — — US disclosed
US-20210078987-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Autophagysciences Inc. (KR) 2021-03-18 — — US disclosed
CN-112004807-A Novel compounds and pharmaceutical compositions comprising said compounds 自体吞噬科学有限公司 2020-11-27 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11407744-B2 Compound and pharmaceutical composition comprising same TFEB, ATG7, BECN1 RAB9A 248/4885NPC1 24/4885TP53 224/4885
US-20210078987-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME TFEB, ATG7, BECN1 RAB9A 194/4885NPC1 25/4885TP53 369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback